| INTRODUCTION
Sedation for precooperative or highly anxious pediatric patients is often required for diagnostic procedures such as electroencephalogram (EEG), magnetic resonance imaging (MRI), electrocardiogram (ECG), computed tomography (CT), and transthoracic echocardiography (TTE).
Ketamine has been used for procedural sedation including by the intranasal route, 1-4 but it has some undesirable side effects -nausea, hypertension, and tachycardia. Dexmedetomidine is useful as a sedative/hypnotic, and offers the advantage of having both sedative and anxiolytic effects, as well as relatively mild analgesic properties and a relatively short elimination half-life of 2 h. 5 Dexmedetomidine has been useful by the intranasal route, [6] [7] [8] [9] [10] but has some drawbacks in terms of effectiveness, onset and offset time.
The potential hemodynamic effects of dexmedetomidine include bradycardia and hypotension, especially when larger doses are administered. It has been shown that dexmedetomidine may reduce the incidence of salivation, hypertension, tachycardia and emergence phenomena from ketamine; Ketamine may prevent bradycardia and hypotension of dexmedetomidine. A combination of dexmedetomidine and ketamine can effectively increase the speed of onset of sedation, thereby eliminating the slow onset time when dexmedetomidine is used as the sole agent. 11 Combination of ketamine and dexmedetomidine by the intranasal route has not been widely reported, but is logical because the effects of the drugs are complementary.
We present a large dataset of the use of this combination for diagnostic procedures in an outpatient setting. Our aim was to evaluate the rate of successful sedation and adverse events of intranasal procedural sedation using a combination of dexmedetomidine and ketamine for diagnostic examination in children.
| PATIENTS AND METHODS

| Patient population
This was a retrospective study in which we evaluated outpatient records to identify patients who were sedated using the combination of dexmedetomidine 2 μg kg −1 and ketamine 1 mg kg −1 by the intranasal route. The protocol was approved by the Institutional Review
Board of the Children's Hospital of Chongqing Medical University.
We screened outpatient medical records by looking at electronic records from our hospital database to identify all patients using a combination of dexmedetomidine and ketamine as their sedation agents from April 2016 to October 2017.
| Sedation method
During the study period, our standard procedure included an anesthesiologist evaluated the patient's general condition, history of past illnesses, characteristics of present illness, history of past surgical procedures, allergies, and history of sedation, before deciding on the type of sedation method. Intranasal dexmedetomidine and ketamine were routinely used in our hospital to sedate children, unless there were clear contraindications (eg, allergies to dexmedetomidine or ketamine, renal or hepatic dysfunction, symptomatic airway obstructions, severe cardiac arrhythmias such as II-and III-degree heart block, intracranial hypertension, and anatomical anomaly of the nasal cavity).
After evaluation by the attending anesthesiologist, the patient was closely monitored, and the relevant data were recorded. The attending nursing officer prepared the sedation medicine according to the weight of the patient using a 1 mL tuberculin syringe. The patient's nasal passages were cleaned before intranasal sedation. The undiluted drug with 2 μg kg −1 dexmedetomidine and 1 mg kg
ketamine was administered slowly into both nostrils by the nurse after the patient fasted for at least 1 h (the concentrations of dexmedetomidine and ketamine were 100 mg ml −1 and 50 mg ml What is already known
• Pediatric patients often require sedation.
• The use of intranasal dexmedetomidine is well described in the literature.
What this article adds
• Procedural sedation using a combination of intranasal dexmedetomidine and ketamine is associated with acceptable effectiveness and low rates of adverse events.
Anesthesiologists physical status (ASAPS) Class 1-2 patients and ASAPS Class 3 patients with normal cardiopulmonary function were escorted to the examination room by a nurse. ASAPS Class 3 patients with abnormal cardiopulmonary function and ASAPS Class 4 patients were escorted by an anesthetist). In the examination room, the attending physicians monitored the patients breathing and heart rate using a portable monitor.
Upon completion of the examination, the attending operators would contact the nurse of the sedation center, then patients were taken back to the sedation center by the nurse. The patients recovered in bed or in the arms of their parents until they were discharged. Parents were encouraged to wake up their children with gentle tactile stimulation or by calling their names. Children were discharged upon attaining a Modified Aldrete Score (MAS) of 9 (for cyanotic congenital heart disease patients, a MAS of 8).
1. Sedation success was defined as successful completed the diagnostic examination and obtained adequate diagnostic-quality images and reports. (minimum dose: 0.1 mg; maximum dose: 0.5 mg) would be given);
(c) blood oxygen saturation (SpO 2 ) reduction to <90% (for cyanotic congenital heart diseases, reduction of <10% of the baseline value);
(d) upper airway obstructions (without airway interventions, and recovered by airway repositioning, supplemental oxygen, and suctioning); (e) delayed awakening, defined as a sedation time of >2 h; or (f) rash.
| Data collection
We collected information on age, weight, gender, ASAPS, fasting time, successful sedation rate, sedation time, type of examination, primary diagnosis and any adverse events encountered during treatment.
| Statistical analysis
Descriptive statistics were calculated using counts, frequencies, 3 | RESULTS
| Demographics and sedation characteristics
For the period of April 2016 to October 2017, a total of 17 948
cases were included in our analysis (Figure 1 ). Demographics and sedation characteristics of the included cases are illustrated in Table 1 . The majority of patients who were sedated were <5 years of age, 13 461 were <3 years old (75%), and 2153 were older than 
| Diagnostic examinations
The diagnostic examinations applied to the study subjects are summarized in Figure 3 . Color Doppler ultrasound, pulmonary function, and EEG accounted for the majority (92.3%) of all diagnostic examinations applied to the study cases.
In our study, a total of 2045 cases received a combination of intranasal dexmedetomidine and ketamine for procedural sedation of EEG from April to December 2016, which included electrode placement for actual recording. We later found that ketamine affected EEG reading and that these patients particularly susceptible to PONV. This observation is consistent with that reported in other published studies. [13] [14] [15] [16] After this date, we opted to use intranasal dexmedetomidine for procedural sedation for EEG's. (Table 1) .
For MRI cases, intranasal success rate was 60% (n = 430); in the remaining 287 subjects, intranasal sedation rescue was 32.4%
(n = 93), and intranasal sedation failure was 67.6% (n = 194). For cases of failed sedation, complete inspection was achieved by inhalation sedation with sevoflurane.
| Major adverse events
Three patients had to undergo emergency airway management Table 2 . Age, weight, and time expressed as median and interquartile ranges; the other variables expressed as numbers (%). Sedation time was defined as the time from drug administration to discharge from hospital; time for onset of sedation was defined as the time from drug administration to the onset of satisfactory sedation. Sedation recovery time was defined as the time from satisfactory sedation to discharge from hospital. Abbreviations: APAPS, American Society of Anesthesiologists physical status; NPO, nil per os.
| Minor adverse events
In total, minor adverse events occurred in 105 cases (0.59%; 95% CI: 0.48-0.71) ( Table 3) 
| DISCUSSION
This is a large-scale retrospective analysis of the rate of sedation success and adverse events associated with sedation using intranasal dexmedetomidine and ketamine among infants and children in a large tertiary hospital in China.
The sedation success rate of our analysis is similar or higher than those reported in previous studies, 9, 10, 17 and sedation time and onset time are shorter than other studies. 8, 18 The reason behind this observation may be due to the combination therapy approach of dexmedetomidine and ketamine. Qiao found that the combination of | 89 dexmedetomidine and ketamine was superior to either dexmedetomidine or ketamine when given alone. 19 Patients who required a second dose of intranasal medication with sedation failure were patients who underwent MRI examination, or had fever, cyanotic congenital heart disease, a history of congenital heart disease surgery, or a history of repeated sedation. The requirement for a second dose of medication was more likely to have a longer procedure.
A recent report indicated that the median effective dose of intranasal dexmedetomidine for TTE after cardiac surgery was higher than that required for normal children. 20 The reason for this remains unclear. It could be envisaged that a high initial dose may improve the success rates of sedation but further research is needed to validate the safety and efficacy of high-dose intranasal sedation.
Our study found that the most minor adverse event was PONV (n = 53, 0.30%); All of the reported cases of PONV ceased with rest or injection of ondansetron (0.08 mg kg
−1
). A number of studies reported PONV as the most common adverse effect of intranasal ketamine, with an incidence rate ranging from 4.7% to 35.3%. 1, 19, [21] [22] [23] [24] [25] The rate of PONV in our study is significantly lower than other reports. The reason may be related to the use of low-dose ketamine.
When defining adverse events related to this sedation regimen, we opted for the use of normal, age-adjusted values for better definition of predicted baseline mean arterial blood pressure and heart rate. 12, 26, 27 For our study, 7.3% (n = 1310) of children experienced an unexpected change in heart rate or blood pressure by >20% normal age-adjusted values. Our study are lower than those in previous studies of dexmedetomidine sedation. 9, 10, 28 This may be related to the combined use of ketamine. Some studies reported there was less hypotension when ketamine was added to dexmedetomidine. 19, 29 Numerous published studies found no adverse respiratory events associated with the use of intranasal dexmedetomidine and/or ketamine. 4, [6] [7] [8] 29 Rate of respiratory events observed in this study is simi- 
| CONCLUSION S
Procedural sedation using a combination of dexmedetomidine and ketamine administered intranasally is associated with acceptable effectiveness and low rates of adverse events in a large cohort of children undergoing nonpainful procedures in our hospital. Further study data are warranted using a variety of dosage regimes in order to achieve satisfactory sedation for some patient subgroups as well as to explore the safety and efficacy profile of larger doses.
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